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Study objective: Two modes of noninvasive home mechanical ventilation (NIHMV)
with volumetric ventilators were compared in patients with chronic respiratory
failure.
Design: Retrospective, parallel-group, comparative study.
Setting: Third-level teaching Hospital in Barcelona (Spain).
Patients and methods: We studied 110 patients with chronic hypercapnic
respiratory failure secondary to neuromuscular disease, kyphoscoliosis or
post-tuberculosis sequelae, starting NIHMV with volumetric ventilators. The
assist/control (A/C) ventilation mode was used in 45 patients and the control
(C) mode in 65 patients. Clinical characteristics, pulmonary function results and
arterial blood gas findings were assessed in each patient before establishing
ventilation and at 6 and 12 months after. The patient’s satisfaction with ventilation,Elsevier Ltd. All rights reserved.
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X. Mun˜oz et al.674the time required for adaptation, and compliance with the prescription were also
assessed.
Measurements and results: Significant improvements in PaO2 and PaCO2 (Po0:001)
were found at 6 and 12 months with both modes of mechanical ventilation.
There were no significant differences between the two modes for pulmonary
function or blood gas parameters with the exception of maximum inspiratory
pressure (MIP) in patients receiving the C mode, which was significantly different as
compared to the baseline value after 12 months of use (mean7SD: 36.6714.8 and
44.7724.2 cmH2O, respectively; P ¼ 0:010). No significant differences were found in
adaptation, compliance with ventilation or patient satisfaction between the two
modes studied.
Conclusions: According to several factors analysed, results with the A/C or C mode
used with volumetric ventilators appear to be comparable in patients with chronic
respiratory disease receiving NIHMV. Choice of mode will depend on the acquired
experience of the prescribing physicians in each centre.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Noninvasive positive pressure home mechanical
ventilation (NIHMV) is an effective technique for
the treatment of chronic respiratory failure in
patients with restrictive pathology secondary to
neuromuscular disease or chest cage alterations.1 A
recent consensus conference has established that
ventilation should be started in these patients
when they present with symptoms such as fatigue,
dyspnea, morning headache and one of the follow-
ing physiological criteria: PaCO2445mmHg or
nocturnal oximetry demonstrating oxygen satura-
tion o88% for 5 consecutive minutes, or (in
progressive neuromuscular disease) a maximum
inspiratory pressure (MIP) o60 cmH2O or FVC
o50% of predicted.2
Volumetric or bilevel positive airway pressure
(BIPAP) ventilators are used for NIHMV. Several
studies have compared different types of ventila-
tors in patients with chronic respiratory failure.
Scho¨nhofer et al.3 and Smith and Shneerson4
concluded that volume-cycled ventilation may
be superior to pressure-cycled ventilation. In
contrast, Restrick et al.5 found no difference
in overnight oxygenation when chronic respiratory
failure patients used volume-targeted ventilation
versus pressure-targeted ventilation for one
night each. Volume-limited ventilators are pre-
ferred for patients with severe neuromuscular
weakness who can be taught to ‘‘stack’’ breaths
to achieve large tidal volumes, enhancing airflow
during coughing and aiding in the expulsion of
secretions.6
Generally, three modes of ventilation are used
with volumetric ventilators: control (C) mode, in
which the machine determines respiratory fre-
quency, assist mode, in which the machine aug-ments the patient’s spontaneous breathing, or
assist/control (A/C) mode, a combination of the
two.7 Parreira et al.8 studied the efficacy of the C
versus the assist mode in positive pressure ventila-
tors used in healthy subjects, particularly focusing
on the degree of ventilation at the level of the
glottis.9–11 These authors suggested that the initial
ventilator setting in C mode should be at a
respiratory frequency of around 20 breaths/min,
with an inspiratory to expiratory (I/E) ratio of 1,
inspiratory positive airway pressure (IPAP) of
15 cmH2O, and maintaining the expiratory positive
airway pressure (EPAP) as low as possible. There
are, however, no studies assessing which mode of
volumetric ventilation is most useful in patients
with chronic respiratory failure secondary to the
aforementioned diseases. This point is important
since some authors have suggested that the C mode
provides better rest for the respiratory musculature
than the A/C mode, thereby improving respiratory
function.12,13
The aim of this study was to compare two
ventilation modes (A/C vs. C) used with volumetric
ventilators for home treatment of chronic respira-
tory failure patients, with regard to pulmonary
function and arterial blood gas results at middle
and long term, as well as the patient’s adaptation
time and satisfaction with the ventilator.Patients and methods
Setting and design
This is a retrospective study comparing parallel
groups, carried out in a third-level teaching
hospital in Barcelona (Spain).
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All patients seen in the Pulmonology Service with
chronic hypercapnic respiratory failure secondary
to neuromuscular disease (excluding amyotrophic
lateral sclerosis), kyphoscoliosis, or post-tubercu-
losis sequelae during the years 1997–2001
were studied. Patients treated with NIHMV by
volumetric ventilator were included in the study
protocol and those with a follow-up time of at
least 1 year were considered eligible for the
statistical analysis. All patients had chronic hyper-
capnia (PaCO2445mmHg) and ventilation was
instituted in the stable phase of the disease in all
cases. Assignment to the A/C mode or the
C mode depended on the criteria of the attending
physician.
The flow chart of the study populations from the
assessment for eligibility to the data analysis is
shown in Fig. 1. During the study period, NIHMV was
started in 151 patients with similar characteristics.
Twenty-five were excluded because BIPAP had beenAssessed
Eligibil
n=151
Assign
n=126
Assigned
n=126
A/C
n=51
Drop-outs
n=16
A/C
n=6
Deaths: n=5
Lost to follow-up: n=1
Low compliance: n=0
Analysed
n=110
A/C
n=45
Figure 1 Flow chart of the study populations. BIPAP, Bilevl pos
Table 1 Causes of death in patients excluded from the
A/C mode (n ¼ 51)
No. of deaths Causes
1 Progression of NM disease
3 Respiratory infection
1 Intestinal occlusion
Total: 5 (9.8%)
NM: neuromuscular, n ¼ number of patients before exclusion, A-Vprescribed for ventilatory support, and the remain-
ing 126 were included in the study protocol. A total
of 16 patients (six in the A/C group and 10 in the C
group) were not included in the final analysis for
the following reasons: 13 had died within 1 year
(10% in the A/C group and 11% in the C group), two
(one in each group) left the study because their
underlying pathologies had improved and ventila-
tion was not required, and one patient from group
C was excluded for noncompliance with the
prescription. The causes of death in these patients
are summarised in Table 1. A total of 110 patients
were included in the final analysis, 45 in the A/C
group and 65 in the C group.
Methods
Initial assessment
Before starting NIHMV, each patient underwent
routine chest radiography, general analyses,
electrocardiography, a complete pulmonary func-
tion study and nocturnal pulse oximetry with the for
ity
Excluded
BIPAP n=25
ed
C
n=75
C
n=10
Deaths: n=8
Lost to follow-up: n=1
Low compliance: n=1
C
n=65
itive pressure ventilation, A/C, assist/control, C, control.
study due to incompletion of 1 year of follow-up.
C mode (n ¼ 75)
No. of deaths Causes
3 Progression of NM disease
3 Respiratory infection
1 Sepsis due to A-V fistula
1 Urinary fistula
Total: 8 (10.6%)
: arteriovenous, A/C: assist/control, C: control.
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(electromyogram, and conventional polysomnogra-
phy) were performed depending on the patient’s
clinical symptoms.
Pulmonary function studies
The pulmonary function studies included forced
spirometry, static lung volume, MIP and expiratory
pressure (MEP) and arterial blood gas testing.
Forced spirometry, static lung volume and MIP and
MEP measurements were done with the Jaeger
system (Jaeger GmbH, Wuerzburg, Germany) ac-
cording to the criteria of the European Respiratory
Society (ERS).14 Static lung volume was measured
with a plethysmographic method. The theoretical
values proposed by Roca et al.15 for the Mediterra-
nean population were used for spirometry and
those of the ERS14 for static lung volume. In
patients with kyphoscoliosis the theoretical value
was obtained by substituting the patient’s height
for the breadth.14
MIP and MEP were measured with a standard
flanged mouthpiece connected to a MasterLab pro
unit, with computation of the average pressure
sustained over 1 s. With a nose clip in place, the
patient performed three maximum inspiratory
efforts from residual volume to generate MIP, with
each effort separated from the next by 30–60 s.
Three maximum expiratory efforts were performed
from total lung capacity to generate MEP. The
reference values used were those of Black and
Hyatt16.
Samples for arterial blood gas testing were
obtained with the patient breathing room air. After
administration of local anaesthesia, the radial
artery was punctured with a heparinised syringe.
Samples were processed immediately. Nocturnal
recording of oxygen saturation by digital pulse
oximetry (Pulsox 7, Minolta, Schaffhausen, Switzer-
land) was performed in all patients before initiating
ventilation and again after the patient had adapted
and was connected to the ventilator. The percen-
tage of time spent with oxygen saturation below
90% (CT90) was calculated from the oximetry
data.17
Institution of mechanical ventilation
Patients were hospitalised for adaptation to me-
chanical ventilation. Custom-made nasal masks
were made for each patient according to the model
proposed by Hospital La Croix Rousse.18,19 A
standard nasal or facemask was used in the
exceptional cases in which it was not possible to
use this procedure. The choice of ventilation mode
in each patient was left to the discretion of the
attending physician (the first three authors of thestudy). The tidal volume, respiratory frequency,
and I/E ratio were adjusted individually, according
to tolerance, air leaks and ventilatory response in
each case. Supplementary oxygen was added when
diurnal O2 saturation during ventilation was less
than 92% or nocturnal CT90 during ventilation
greater than 30% during the follow-up surveillance.
After the parameters had been adjusted and the
patient had adapted to the ventilator, arterial
blood gas testing was used to assess the efficacy of
the settings. The patient was then instructed in the
management of the ventilator and was counselled
in its progressive use, mainly at night.
Follow-up
All patients were given an emergency telephone
number to contact for medical problems and
another for mechanical problems with the respira-
tor (property of the Catalan Health System, which
provides complete public health coverage). Except
for urgent visits, all patients were seen at 1 month,
6 months and 12 months after starting mechanical
ventilation. A clinical interview was performed at
all the visits to determine the adverse effects of
NIHMV, the number of hospitalisations required,
and the patient’s degree of satisfaction with the
ventilator. Degree of satisfaction was assessed with
a qualitative scale using a score of 1–5: 1 (very
bad), 2 (bad), 3 (regular), 4 (good), 5 (very
good).20,21 In addition, patients underwent a
complete pulmonary function study and room-air
arterial blood gas testing. Finally, objective com-
pliance with the prescription was assessed by
means of the counter installed on the system.
Proper compliance was defined as use of the
ventilator a minimum of 4 h daily. Patients were
considered to have adapted when they were
comfortable, their respiration was synchronised
with the respirator, there were no leaks and oxygen
saturation values were stable by digital pulse
oximetry. Synchrony with the respirator was
assessed clinically, both while the patient was
awake and sleeping. The presence of leaks
was determined with a spirometer connected to
the expiratory valve in the waking assessment
and by nocturnal pulse oximetry in the sleeping
evaluation.
Statistical analysis
Baseline descriptive data were described as fre-
quencies and percentages for qualitative data and
mean and standard deviation (SD) for quantitative
data. Absolute changes in respiratory test results
relative to baseline at different time points were
also described by 95% confidence intervals (95%CI).
Between-group comparisons used Fisher’s exact
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for quantitative variables. Within-group compar-
isons used the t-test for dependent measurements.
All significance tests were two-tailed.Results
The characteristics of the patients in each ventila-
tion mode group before starting mechanical venti-
lation are shown in Table 2. The ventilation dataTable 2 Baseline characteristics according to the mode
Baseline characteristics A/C (n ¼ 45)
Male sex, n (%) 23 (51.1%)
Age (years) 65.1712.9
Current disease
Neuromuscular, n (%) 10 (22%)
Post-TB lesions, n (%) 19 (42%)
Kyphoscoliosis, n (%) 16 (36%)
PaO2(RA) (mmHg) 55.8712.3
PaCO2(RA) (mmHg) 59.1714.0
Respiratory function tests
FVC% 31.4710.0
FEV1% 29.3711.2
FEV1/FVC% 69.2714.8
MIP (cmH2O) 35.9716.0
MEP (cmH2O) 68.6728.6
CT90 74.7733.3
TB: tuberculosis, FEV1: forced expiratory volume in 1 s, FVC: for
o90%, MEP: maximum expiratory pressure, MIP: maximum insp
(room air), PaO2 (RA): arterial oxygen tension (room air), A/C: ass
Descriptive values indicate either n (%) or mean7standard de
Table 3 Airway access and characteristics of NIHMV acc
Baseline characteristics A/C (n ¼ 45Þ
Respiratory frequency (r/m) 16.872.7
Trigger (mbar) From 1.5 to
I/E
o1/1.4 (n) 17
1/1.5/1/1.9 (n) 12
41/2 (n) 9
Supplementary O2 9
Tidal volume (mL/Kg) 9.570.7
Airway access
Custom-made nasal mask 43 (95.5%)
Standard nasal mask 1 (2.2%)
Face mask 1 (2.2%)
+Comparisons between these variables were not performed.
I/E: inspiratory to expiratory ratio, A/C: assist/control, C: contro
Descriptive values indicate either n or n (%) or mean7standaare summarised in Table 3. At baseline there were
no significant differences between the groups for
any values except the FEV1/FVC% ratio (P ¼ 0:024).
Thirty minutes after starting ventilation and with
the patients connected to the ventilator, PaO2(MV)
(mean7standard deviation) was 71.7714.3 in the
A/C group (Po0:001 with respect to baseline
[WRB]) and 72.4717.7 in the C group (Po0:001
WRB). PaCO2(MV) was 43.979.7 (Po0:001) and
43.6711.3 (Po0:001), respectively. CT90 values
at the time of hospital discharge were 25.8724.4of ventilation used.
C (n ¼ 65) P-value
35 (53.8%) 0.847
60.3714.7 0.087
19 (29%) 0.469
19 (29%) 0.469
27 (42%) 0.469
57.8711.0 0.371
55.278.1 0.069
33.1711.4 0.429
32.7712.2 0.145
75.6713.4 0.024
36.6714.8 0.864
62.0729.1 0.343
86.0727.0 0.235
ced vital capacity, CT90: percent of time with O2 saturation
iratory pressure, PaCO2 (RA): arterial carbon dioxide tension
ist/control, C: control.
viation.
ording to the mode of ventilation used.
C (n ¼ 65) P-value
16.771.9 0.918
0.5 —
36 +
26 +
3 +
6 +
8.6171.6 +
63 (96.9%) 0.875
2 (3.1%) 0.875
0 (0%) 0.875
l.
rd deviation.
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X. Mun˜oz et al.678(Po0:001 WRB) in the A/C group and 31.4728.8
in the C group (Po0:001 WRB). There were no
significant differences between the groups in
PaO2 (MV), PaCO2(MV) or CT90 (P ¼ 0:824, 0.905,
and 0.485, respectively). The time required for
adaptation to the ventilator in the hospital was
11.679.4 days in the A/C group and 11.478.9
days in the C group (P ¼ 0:930).
Tables 4 and 5 show the changes in respiratory
function values in the two groups of patients at 6
and 12 months, respectively, after the start of
ventilation. Arterial blood gas parameters
showed significant differences as compared to
baseline in both groups. PaO2(RA) and PaCO2(RA)
values were comparable in the two groups at 6
and 12 months, and were significantly different
as compared to baseline. There were no differ-
ences between the groups in the degree of
improvement in blood gas or pulmonary function
results at 6 and 12 months (P40:05). Significant
differences were found between MIP values at
baseline and 12 months (36.6+14.8 and
44.7+24.2 cmH2O, respectively; P ¼ 0:010) only
in patients receiving the C mode.
Adverse effects were similar in the two groups,
with the most frequent being nasal ulcers in 13
patients (6 A/C and 7 C), oral leaks (5 A/C and 5
C), conjunctivitis (3 A/C and 2 C), abdominal
distension (3 A/C and 4 C) and rhinitis (3 A/C and
3 C). Mechanical ventilation did not have to be
interrupted in any case due to adverse effects
and no patient had to change from one mode to
the other after the adaptation period. There
were no significant differences between the
groups with respect to the number of hospitalisa-
tions during the study period: 0.1770.4 per
patient in the A/C group and 0.0470.2 per
patient in the C group (P ¼ 0:109).
Objective compliance at 12 months after
initiating ventilation was 8.672.4 h/day for the
A/C group and 8.971.6 h/day for the C group
(P ¼ 0:623). The patient’s degree of satisfaction
at 1 month after the initiation of ventilation,
expressed on a scale of 1 to 5 points was 3.9 (r:
2–5) and 4 (r: 1–5) for the A/C and C groups,
respectively. At 12 months, degree of satisfaction
was 4.9 (r: 4–5) for both groups.Discussion
This study shows that the use of NIHMV with a
volumetric ventilator in patients with respiratory
failure secondary to restrictive disease results in
improved PaO2 and PaCO2 values at middle and
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Two modes of NIHMV in chronic respiratory failure 679long term. The improvement was significant and
was seen in both the C and A/C modes of
mechanical ventilation. In addition, adaptation
and compliance were favourable, and there was a
high degree of patient satisfaction regardless of the
ventilation mode applied.
As was mentioned in the Introduction, to our
knowledge, there are no studies in the literature
assessing potential differences between these
ventilation modes when using a volumetric venti-
lator. A study by Perreira et al.8 in pressure-cycled
ventilators has suggested that the C mode may give
better results. In contrast, other studies have
indicated that the C mode is associated with a
lower respiratory workload, greater discomfort for
the patient and a lengthier period of adaptation to
the ventilator.1,8,22 Among the patients included in
the present study the adaptation period was similar
in both the A/C and C groups (A/C, 11.679.4 days
and C, 11.478.9 days) and the patients’ degree of
satisfaction was found to be ‘‘very good’’ for the
two ventilation modes, with no significant differ-
ences. These findings concur with those from a
report by Pehrsson et al.,21 in which patient
satisfaction with home mechanical ventilation,
expressed with a visual analogue scale of 1–7 (from
very dissatisfied to very satisfied), was 6.1
(SEM ¼ 0.18, range 3–7).
The time required for adaptation to NIHMV has
not been well established in the literature. Several
studies have suggested that it may vary according
to the characteristics of each patient, the presence
of underlying diseases, and the type of ventilator
and mask used.23–27 In the setting of chronic
disease, patients generally start gradually and
periods of use are increased as tolerated. Many
patients begin with only 1 or 2 h during the day and
at night. Gradually, over several weeks or even
months, these periods are extended to cover the
entire night.1 Although the time of adaptation in
the present study was approximately 11 days for
both groups, this period may be longer or shorter
according to the experience of the centres and the
co-operation of patients and their families. It is
important to mention that adherence to therapy
was good in all our patients, generally covering
periods of 8–9 h per day, regardless of the mode of
ventilation used.
To our knowledge, this is the first study assessing
differences between ventilation modes in patients
with the restrictive respiratory diseases cited. Poten-
tial sources of bias that could affect the comparability
of the results (e.g., in the baseline characteristics or
patients excluded) were not detected. The only
variable showing a significant between-group differ-
ence at baseline was FEV1/FVC%, although it had
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believe that the difference would affect the results
obtained. Nevertheless, this was not a randomised
study and the choice of ventilation mode depended on
the criteria of the attending physician; therefore, the
adaptation assessment should be interpreted with
caution. Furthermore, due to the characteristics of
the study, we did not know if, before adapting to a
certain ventilation mode, the patient had tried and
abandoned the opposing mode.
One mechanism related to this treatment that
remains undefined is how nocturnal noninvasive
ventilation stabilises or improves daytime gas
exchange during spontaneous breathing in patients
with chronic respiratory failure. Some authors have
proposed that noninvasive ventilation rests chroni-
cally fatigued respiratory muscles, thereby improv-
ing daytime respiratory muscle function.12,13,28–34
Along this line it would be logical to assume that
use of a controlled mode of ventilation, in which
the patient does not have to exert any inspiratory
effort, would result in better resting of the
musculature and a better response. Although there
was a statistically significant improvement in the
MIP at 12 months after initiating NIHMV in patients
prescribed the C mode, we cannot conclude that
this fact was responsible for the blood gas
improvements observed, since similar benefits
were seen in the patients receiving the A/C mode.
In summary, NIHMV with volumetric ventilators is
a useful method for treating patients with chronic
hypercapnic respiratory insufficiency secondary to
neuromuscular disease, kyphoscoliosis, or post-
tuberculosis sequelae, with no differences in the
outcome of its use in either the A/C or C mode. The
use of one mode or the other will probably depend
on the acquired experience of the prescribing
medical team in each centre.References
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